Logo image of HHR

HeadHunter Group PLC (HHR) Stock Fundamental Analysis

NASDAQ:HHR - Nasdaq - US42207L1061 - ADR - Currency: USD

15.03  +0.04 (+0.27%)

Premarket: 12.69 -2.34 (-15.57%)

Fundamental Rating

3

HHR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. HHR has a bad profitability rating. Also its financial health evaluation is rather negative. HHR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HHR had positive earnings in the past year.
HHR Yearly Net Income VS EBIT VS OCF VS FCFHHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 1B 2B 3B

1.2 Ratios

Industry RankSector Rank
ROA 20.93%
ROE 84.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HHR Yearly ROA, ROE, ROICHHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 10 20 30 40 50

1.3 Margins

Industry RankSector Rank
OM -3.28%
PM (TTM) 32.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HHR Yearly Profit, Operating, Gross MarginsHHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

HHR has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for HHR is higher compared to a year ago.
HHR Yearly Shares OutstandingHHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 10M 20M 30M 40M
HHR Yearly Total Debt VS Total AssetsHHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 5B 10B 15B

2.2 Solvency

HHR has an Altman-Z score of 4.10. This indicates that HHR is financially healthy and has little risk of bankruptcy at the moment.
HHR has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z 4.1
ROIC/WACCN/A
WACCN/A
HHR Yearly LT Debt VS Equity VS FCFHHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.84 indicates that HHR may have some problems paying its short term obligations.
HHR has a Quick Ratio of 0.84. This is a bad value and indicates that HHR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
HHR Yearly Current Assets VS Current LiabilitesHHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 1B 2B 3B 4B 5B

More info and screens

9

3. Growth

3.1 Past

HHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 105.12%, which is quite impressive.
HHR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.69% yearly.
Looking at the last year, HHR shows a very strong growth in Revenue. The Revenue has grown by 75.88%.
HHR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.69% yearly.
EPS 1Y (TTM)105.12%
EPS 3Y61.79%
EPS 5Y6.69%
EPS Q2Q%137.56%
Revenue 1Y (TTM)75.88%
Revenue growth 3Y20.51%
Revenue growth 5Y21.69%
Sales Q2Q%103.21%

3.2 Future

HHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.44% yearly.
HHR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.42% yearly.
EPS Next Y110.59%
EPS Next 2Y67.11%
EPS Next 3Y53.17%
EPS Next 5Y43.44%
Revenue Next Year88.63%
Revenue Next 2Y55.13%
Revenue Next 3Y43.34%
Revenue Next 5Y35.42%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HHR Yearly Revenue VS EstimatesHHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B
HHR Yearly EPS VS EstimatesHHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 100 200 300

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.02, the valuation of HHR can be described as correct.
HHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.05.
HHR is valuated reasonably with a Price/Forward Earnings ratio of 8.38.
HHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.07.
Industry RankSector Rank
PE 12.02
Fwd PE 8.38
HHR Price Earnings VS Forward Price EarningsHHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.25
HHR Per share dataHHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

HHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HHR's earnings are expected to grow with 53.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)1.8
EPS Next 2Y67.11%
EPS Next 3Y53.17%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.25%, HHR is a good candidate for dividend investing.
The stock price of HHR dropped by -70.93% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
HHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 9.25%

5.2 History

HHR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
HHR Yearly Dividends per shareHHR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 0.2 0.4 0.6 0.8

5.3 Sustainability

46.17% of the earnings are spent on dividend by HHR. This is a bit on the high side, but may be sustainable.
DP46.17%
EPS Next 2Y67.11%
EPS Next 3Y53.17%
HHR Yearly Income VS Free CF VS DividendHHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 500M 1B 1.5B 2B 2.5B
HHR Dividend Payout.HHR Dividend Payout, showing the Payout Ratio.HHR Dividend Payout.PayoutRetained Earnings

More info and screens

HeadHunter Group PLC

NASDAQ:HHR (2/25/2022, 8:00:02 PM)

Premarket: 12.69 -2.34 (-15.57%)

15.03

+0.04 (+0.27%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)03-21 2022-03-21
Earnings (Next)05-25 2022-05-25
Inst Owners0.01%
Inst Owner Change-61.43%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap761.05M
Analysts82.35
Price Target68.14 (353.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.25%
Yearly Dividend0.38
Dividend Growth(5Y)N/A
DP46.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.02
Fwd PE 8.38
P/S 4.52
P/FCF N/A
P/OCF N/A
P/B 11.88
P/tB N/A
EV/EBITDA 9.25
EPS(TTM)1.25
EY8.32%
EPS(NY)1.79
Fwd EY11.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.32
BVpS1.27
TBVpSN/A
PEG (NY)0.11
PEG (5Y)1.8
Profitability
Industry RankSector Rank
ROA 20.93%
ROE 84.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.28%
PM (TTM) 32.33%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 4.1
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.12%
EPS 3Y61.79%
EPS 5Y6.69%
EPS Q2Q%137.56%
EPS Next Y110.59%
EPS Next 2Y67.11%
EPS Next 3Y53.17%
EPS Next 5Y43.44%
Revenue 1Y (TTM)75.88%
Revenue growth 3Y20.51%
Revenue growth 5Y21.69%
Sales Q2Q%103.21%
Revenue Next Year88.63%
Revenue Next 2Y55.13%
Revenue Next 3Y43.34%
Revenue Next 5Y35.42%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A